Table 1.
Summary of profibrotic factors that have been targeted with AOs.
Pro-Fibrotic Factor | Function | Model | References |
---|---|---|---|
TGFβ1 | Pro-fibrotic master—regulator | In vitro and in vivo rodent models of renal fibrosis | [92,93,94] |
In vivo mouse model of tendon scarring | [95] | ||
In vitro models of hepatic fibrosis | [96] | ||
ALK5 | Component of canonical TGFβ1 receptor—TGFβ1 signaling | Ex vivo in cultures of Dupuytren’s patient tissue | [91] |
In vivo mouse model of DMD | [102] | ||
SMAD3 | Component of canonical TGFβ1 signaling pathway | In vitro culture of human keloid fibroblasts | [104] |
In vivo mouse model of tendon scarring | [95] | ||
In vitro and in vivo mouse models of renal fibrosis | [105] | ||
Connexin43 | Component of gap junctions—pro-fibrotic factor | In vitro culture of rat cardiac fibroblasts | [63] |
In vivo model of rabbit eye glaucoma trabeculectomy | [68] | ||
In vivo neonatal mouse model of burn injury | [66] | ||
miR-21 | Pro-fibrotic miR | In vivo mouse model of cardiac fibrosis | [106] |
In vivo mouse models of renal fibrosis | [107] | ||
In vivo mouse models of pulmonary fibrosis | [76] | ||
miR-192 | Pro-fibrotic miR | In vivo mouse models of renal fibrosis | [75] |
miR-208a | Pro-fibrotic miR | In vivo rodent models of vascular and cardiac fibrosis | [108,109] |
miR-34 | Pro-fibrotic miR | In vivo mouse and rat models of cardiac fibrosis | [110,111] |
CTGF | Downstream pro-fibrotic effector of TGFβ1 | In vivo neonatal mouse model of burn injury | [66] |
In vivo rabbit model of hypertrophic scarring | [129] | ||
In vivo mouse model of tendon scarring | [95] | ||
Periostin | Downstream pro-fibrotic effector of TGFβ1 | In vivo rat model of renal injury | [17] |
In vivo mouse model of renal fibrosis | [151] | ||
In vivo mouse model of surgically induced adhesions | [152] | ||
In vivo mouse model of pulmonary fibrosis | [153] | ||
Cultures of multiple human cell lines | [155] | ||
TIMPs | MMP inhibitors and pro-fibrotic factors | In vivo rat model of pulmonary fibrosis | [160] |
In vivo rat model of hepatic fibrosis | [161,162] | ||
bFGF * | Cytokine—pro-fibrotic factor | In vivo rat model of pulmonary fibrosis | [163] |
Kras * | Monomeric GTPase—component of signal transduction pathways | In vivo rat model of renal fibrosis | [164] |
Sp1 * | Transcription factor | In vitro culture of human dermal fibroblasts and in vivo in murine skin | [165] |
NF-κB * | Transcription factor | In vivo mouse model of pulmonary fibrosis | [166] |
In vivo mouse model of interstitial fibrosis | [167] | ||
STAT1 * | Transcription factor | In vivo rat model of pulmonary fibrosis | [168] |
HSP27 * | Chaperone | In vitro and in vivo rat model of pulmonary fibrosis | [169] |
* These factors are not discussed in the main text of the review.